EBR Price sensitive 12 Jan 2026, 8:30 AM

Strong Q4 FY2025 Commercial and Clinical Progress

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.